Tag Archives: cardiorenal outcomes
Tirzepatide: 22,104 Matched Bariatric-Surgery Patients
Tirzepatide or GLP-1RA use before bariatric surgery was associated with fewer 90-day cardiorenal events in 22,104 matched patients.
No account yet?
Create an AccountJoin the list for batch updates and new compound announcements. We will send you a single-use 8% code once you confirm your address.
Every batch is tested separately
Purity is measured per production lot, not once per product.
See the batch records